Blog posts by Angelica Kershaw
19 August 2016 by
Public health experts have welcomed the new approach of some pharmaceutical companies towards unveiling new patent...
27 June 2016 by Angelica Kershaw
Earlier this month, the Colombian health ministry put an end to a debate that had extended for more than a year with the...
21 April 2016 by Angelica Kershaw
Following recent confirmation by the US Center for Disease Control and Prevention (CDC) and the World Health Organisation (WHO)...
26 October 2015 by Angelica Kershaw
While attending the 5th ISPOR Latin American Conference that took place in Chile last month, my attention was drawn to the variety...
27 May 2015 by Angelica Kershaw
During recent months, shortages of medicines have increased in Venezuela to such a level that several international...
13 April 2015 by Angelica Kershaw
After several months of discussion, the Colombian government has given the green light to the so called "healthcare statutory...
17 February 2015 by Angelica Kershaw
Former Cuban leader Fidel Castro recently gave his approval for talks between the US and Cuba aimed at restoring...
1 August 2014 by Angelica Kershaw
From a government perspective, the potential benefits of biosimilars are pretty clear: they offer great potential to...
About the Life Sciences BlogIndustry insights from the IHS Markit Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence. IHS Markit Blog Home »
Tweets by @IHS4LifeScience